NSF International is partnering with the Indian Drug Manufacturers’ Association (IDMA) to offer a customised, five-module pharmaceutical quality management (PQM) education programme in Bangalore, India
Pharmaceutical industry professionals who complete the graduate-level, advanced education programme will earn an internationally recognised certification in GMP compliance from NSF International and IDMA.
The Advanced Programme in Pharmaceutical Quality Management consists of five modules, each lasting 4 days. With the modules taught every other month, the programme can be completed in 10 months. Classes will be offered at Acharya College in Bangalore with a planned start in September 2017.
Together with IDMA, we’re going to change how course participants think about quality.
India has the highest number of GMP-approved manufacturing plants outside the United States and Europe. As global regulatory requirements become more rigorous, GMP compliance education is becoming a prime focus for the pharmaceutical industry.
“This programme provides the training needed to comply with GMP requirements in Europe and the United States,” said Martin Lush, Global Vice President of Pharma Biotech and Medical Devices for NSF International. “Together with IDMA, we’re going to change how course participants think about quality and give them the knowledge and tools they need to protect their company’s legacy, reputation and future.”
The training programme is designed to be highly interactive and includes modules covering best practices in PQM systems, change control and deviations, human factors in quality management, practical application of statistics, and process validation and technology transfer.
The course also includes practical instruction on the leadership and communication skills required to improve business performance and regulatory compliance at pharmaceutical manufacturing operations and to successfully interact with regulatory agencies in the United States and the EU.
To discover more, meet NSF at Making Pharmaceuticals (stand 214).